Insights

Orphan CNS Focus Saol concentrates on CNS disorders with an emphasis on orphan diseases and is advancing PDCD programs, creating demand for specialized trial execution, patient recruitment, and genomics-driven screening. The company’s collaboration with GeneDx demonstrates openness to external partners that can help identify eligible patients.

Global Footprint With operations in the United States, Ireland, and Bermuda, Saol can collaborate across regulatory jurisdictions and optimize regional supply chains, enabling EU/UK commercialization, regional manufacturing, and distribution partnerships.

Partnership History Saol has pursued strategic collaborations and co-promotion with partners, and has engaged in licensing and asset transactions, signaling a willingness to explore licensing, co-development, or commercialization deals to extend its reach.

Pipeline Readiness The pipeline includes CNS programs and ultrarare disease assets, indicating potential for external development, manufacturing support, and market access planning ahead of potential commercialization.

Funding Opportunities With moderate revenue and external funding, Saol may benefit from strategic alliances, licensing, or asset monetization to accelerate development and broaden market access.

Similar companies to Saol Therapeutics

Saol Therapeutics Tech Stack

Saol Therapeutics uses 8 technology products and services including MySQL, oEmbed, Microsoft 365, and more. Explore Saol Therapeutics's tech stack below.

  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Microsoft 365
    Email
  • Google Fonts API
    Font Scripts
  • PHP
    Programming Languages
  • Cloudflare Bot Management
    Security
  • Vimeo
    Video Players
  • DigitalOcean Web Hosting
    Web Hosting

Media & News

Saol Therapeutics's Email Address Formats

Saol Therapeutics uses at least 1 format(s):
Saol Therapeutics Email FormatsExamplePercentage
FLast@saolrx.comJDoe@saolrx.com
76%
Last@saolrx.comDoe@saolrx.com
12%
First@saolrx.comJohn@saolrx.com
8%
FirstLast@saolrx.comJohnDoe@saolrx.com
4%

Frequently Asked Questions

What is Saol Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Saol Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Saol Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Saol Therapeutics's official website is saolrx.com and has social profiles on LinkedInCrunchbase.

What is Saol Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Saol Therapeutics's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Saol Therapeutics have currently?

Minus sign iconPlus sign icon
As of July 2026, Saol Therapeutics has approximately 35 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Operating Officer: P. H.Vice President Of Research & Development: L. O.Qa And Regulatory Affairs Director: M. R.. Explore Saol Therapeutics's employee directory with LeadIQ.

What industry does Saol Therapeutics belong to?

Minus sign iconPlus sign icon
Saol Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Saol Therapeutics use?

Minus sign iconPlus sign icon
Saol Therapeutics's tech stack includes MySQLoEmbedMicrosoft 365Google Fonts APIPHPCloudflare Bot ManagementVimeoDigitalOcean Web Hosting.

What is Saol Therapeutics's email format?

Minus sign iconPlus sign icon
Saol Therapeutics's email format typically follows the pattern of FLast@saolrx.com. Find more Saol Therapeutics email formats with LeadIQ.

How much funding has Saol Therapeutics raised to date?

Minus sign iconPlus sign icon
As of July 2026, Saol Therapeutics has raised $17M in funding. The last funding round occurred on Aug 05, 2019 for $17M.

When was Saol Therapeutics founded?

Minus sign iconPlus sign icon
Saol Therapeutics was founded in 2015.
Saol Therapeutics logo

Saol Therapeutics

Pharmaceutical ManufacturingGeorgia, United States11-50 Employees

Saol Therapeutics is a privately held, clinical-stage pharmaceutical company focused on developing treatments for central nervous system disorders, including pain management and spasticity, as well as orphan diseases. Its work centers on advancing candidates through clinical trials, with multiple studies active in the United States at the present time. The company aims to expand therapeutic options for patients and clinicians treating these populations, supported by collaborations and research activities pursued across its operations in the United States, Ireland, and Bermuda.
Headquartered in Roswell, Georgia, Saol Therapeutics operates within the pharmaceutical manufacturing sector and maintains a global footprint through its offices in Roswell, Dublin, and Hamilton. Its activities have included partnerships and strategic initiatives to identify and enroll patients for rare disease trials, underscoring a focus on identifying underserved patient populations and advancing novel interventions through late-stage development. A notable recent development includes progression in a Phase III trial for a PDCD-related therapy and ongoing Phase II trials, reflecting continued clinical-stage advancement." } API 0.1 0.7 0.3 0.4 0.2 0.5 0.6 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 } 0.72 0.85 0.15 0.70 0.40 0.10 0.60 0.30 0.50 0.20 0.90 0.25 0.35 0.45 0.55 0.65 0.75 0.80 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95 0.05 0.15 0.25 0.35 0.45 0.55 0.65 0.75 0.85 0.95

Section iconCompany Overview

Phone number
Website
saolrx.com
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $17M

    Saol Therapeutics has raised a total of $17M of funding over 1 rounds. Their latest funding round was raised on Aug 05, 2019 in the amount of $17Mas a series_unknown.

  • $25M$50M

    Saol Therapeutics's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $17M

    Saol Therapeutics has raised a total of $17M of funding over 1 rounds. Their latest funding round was raised on Aug 05, 2019 in the amount of $17Mas a series_unknown.

  • $25M$50M

    Saol Therapeutics's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.